Open AccessPatient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer
Author(s) -
Lauren P. Wallner,
David ReyesGastelum,
Ann S. Hamilton,
Kevin C. Ward,
Sarah T. Hawley,
Megan R. Haymart
Publication year - 2019
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.18.02228
Subject(s) - medicine , thyroid cancer , logistic regression , thyroidectomy , odds ratio , likert scale , patient satisfaction , cancer , family medicine , odds , radioactive iodine , surgery , thyroid , statistics , mathematics
For many patients with differentiated thyroid cancer, use of radioactive iodine (RAI) does not improve survival or reduce recurrence risk. Yet there is wide variation in RAI use, emphasizing the importance of understanding patient perspectives regarding RAI decision making.